53 related articles for article (PubMed ID: 9755618)
21. [Interaction of drugs].
Sheĭnbaum EM
Feldsher Akush; 1981; (8):59-61. PubMed ID: 6912148
[No Abstract] [Full Text] [Related]
22. Drugs; some adverse interactions.
Aaron H
Am J Nurs; 1966 Jul; 66(7):1545-6. PubMed ID: 5177339
[No Abstract] [Full Text] [Related]
23. [Drug interactions--which are proven and how can they be avoided?].
Reinicke C
Z Arztl Fortbild (Jena); 1987; 81(13):649-51. PubMed ID: 3687077
[No Abstract] [Full Text] [Related]
24. [Drug incompatibility].
Astaf'ev VA
Feldsher Akush; 1980; 45(11):29-30. PubMed ID: 6906273
[No Abstract] [Full Text] [Related]
25. Interactions between alcohol and drugs.
Soehring K; Schüppel R
Ger Med Mon; 1967 Feb; 12(2):87-90. PubMed ID: 5343283
[No Abstract] [Full Text] [Related]
26. [Drug therapy of the elderly].
Furhoff AK
Lakartidningen; 1983 Jun; 80(23):2431-3. PubMed ID: 6888095
[No Abstract] [Full Text] [Related]
27. Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake.
Monazzam A; Razifar P; Ide S; Rugaard Jensen M; Josephsson R; Blomqvist C; Langström B; Bergström M
Nucl Med Biol; 2009 Apr; 36(3):335-42. PubMed ID: 19324279
[TBL] [Abstract][Full Text] [Related]
28. Application of PET/CT in the development of novel anticancer drugs.
Boss DS; Olmos RV; Sinaasappel M; Beijnen JH; Schellens JH
Oncologist; 2008 Jan; 13(1):25-38. PubMed ID: 18245010
[TBL] [Abstract][Full Text] [Related]
29. A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease.
Bauer M; Langer O; Dal-Bianco P; Karch R; Brunner M; Abrahim A; Lanzenberger R; Hofmann A; Joukhadar C; Carminati P; Ghirardi O; Piovesan P; Forloni G; Corrado ME; Lods N; Dudczak R; Auff E; Kletter K; Müller M
Clin Pharmacol Ther; 2006 Sep; 80(3):216-27. PubMed ID: 16952488
[TBL] [Abstract][Full Text] [Related]
30. First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography.
Schottelius M; Poethko T; Herz M; Reubi JC; Kessler H; Schwaiger M; Wester HJ
Clin Cancer Res; 2004 Jun; 10(11):3593-606. PubMed ID: 15173065
[TBL] [Abstract][Full Text] [Related]
31. [PET as a tool in pharmacologic development].
Bergström M; Hartvig P; Långström B
Nord Med; 1998 Sep; 113(7):226-9. PubMed ID: 9755618
[TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography for use in microdosing studies.
Wagner CC; Müller M; Lappin G; Langer O
Curr Opin Drug Discov Devel; 2008 Jan; 11(1):104-10. PubMed ID: 18175273
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
